Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Statements of changes in convertible preferred shares and shareholders' deficit

v3.22.1
Statements of changes in convertible preferred shares and shareholders' deficit - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018 45,786,714        
Beginning balance at Dec. 31, 2018 $ 96,025        
Ending balance (in shares) at Dec. 31, 2019 45,786,714        
Ending balance at Dec. 31, 2019 $ 96,025        
Beginning balance (in shares) at Dec. 31, 2018   13,171,157      
Beginning balance at Dec. 31, 2018 (114,615) $ 36 $ 16,254 $ (347) $ (130,558)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   498,130      
Exercise of stock options 589 $ 1 588    
Share-based compensation 2,004   2,004    
Other comprehensive income 496     496  
Net loss (17,707)       (17,707)
Ending balance (in shares) at Dec. 31, 2019   13,669,287      
Ending balance at Dec. 31, 2019 $ (129,233) $ 37 18,846 149 (148,265)
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Preferred C Shares, net of issuance cost (in shares) 4,870,328        
Issuance of Preferred C Shares, net of issuance cost $ 39,785        
Ending balance (in shares) at Dec. 31, 2020 50,657,042        
Ending balance at Dec. 31, 2020 $ 135,810        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 1,656,994 1,656,994      
Exercise of stock options $ 1,442 $ 5 1,437    
Share-based compensation 4,800   4,800    
Deemed dividend to ordinary and preferred shareholders 0   825   (825)
Other comprehensive income (73)     (73)  
Net loss $ (21,996)       (21,996)
Ending balance (in shares) at Dec. 31, 2020 15,326,281 15,326,281      
Ending balance at Dec. 31, 2020 $ (145,060) $ 42 25,908 76 (171,086)
Increase (Decrease) in Temporary Equity [Roll Forward]          
Coversion of Convertible Preferred Shares to Ordinary Shares upon initial public offering (in shares) (50,657,042)        
Conversion of Convertible Preferred Shares to Ordinary Shares upon initial public offering $ (135,810)        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of convertible preferred shares to ordinary shares (in shares)   50,657,042      
Conversion of Convertible Preferred Shares to Ordinary Shares upon initial public offering 135,810 $ 136 135,674    
Issuance of shares in relation to initial public offering, net (in shares)   7,550,531      
Issuance of shares in relation to initial public offering, net of issuance costs $ 150,666 $ 23 150,643    
Exercise of stock options (in shares) 1,301,233 1,311,587      
Exercise of stock options $ 1,222 $ 4 1,218    
Share-based compensation 11,171   11,171    
Other comprehensive income 84     84  
Net loss $ (68,979)       (68,979)
Ending balance (in shares) at Dec. 31, 2021 74,845,441 74,845,441      
Ending balance at Dec. 31, 2021 $ 84,914 $ 205 $ 324,614 $ 160 $ (240,065)